1
|
Tirmarche M, Apostoaei I, Blanchardon E, Ellis ED, Gilbert E, Harrison JD, Laurier D, Marsh JW, Sokolnikov M, Wakeford R, Zhivin S. ICRP Publication 150: Cancer Risks from Plutonium and Uranium Exposure. Ann ICRP 2021; 50:1-143. [PMID: 34877884 DOI: 10.1177/01466453211028020] [Citation(s) in RCA: 7] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
2
|
Abstract
Fundamental estimates of radon-associated health risk have been provided by epidemiological studies of miners. In total, approximately 15 studies have been conducted worldwide since the 1960s. These results have contributed directly to radiological protection against radon. The present article summarises the main results, with a focus on analyses of miners exposed more recently, estimates of radon lifetime attributable risk, and interaction between radon and smoking. The potential for the upcoming Pooled Uranium Miner Analysis project to further improve our knowledge is discussed.
Collapse
Affiliation(s)
- D Laurier
- Institute for Radiological Protection and Nuclear Safety, 92262 Fontenay aux Roses Cedex, France; e-mail:
| | | | - E Rage
- Institute for Radiological Protection and Nuclear Safety, 92262 Fontenay aux Roses Cedex, France; e-mail:
| | - L Tomasek
- National Radiation Protection Institute, Czech Republic
| |
Collapse
|
3
|
Abstract
The International Commission on Radiological Protection (ICRP) publishes guidance on protection from radon in homes and workplaces, and dose coefficients for use in assessments of exposure for protection purposes. ICRP Publication 126 recommends an upper reference level for exposures in homes and workplaces of 300 Bq m-3. In general, protection can be optimised using measurements of air concentrations directly, without considering radiation doses. However, dose estimates are required for workers when radon is considered as an occupational exposure (e.g. in mines), and for higher exposures in other workplaces (e.g. offices) when the reference level is exceeded persistently. ICRP Publication 137 recommends a dose coefficient of 3 mSv per mJ h m-3 (approximately 10 mSv per working level month) for most circumstances of exposure in workplaces, equivalent to 6.7 nSv per Bq h m-3 using an equilibrium factor of 0.4. Using this dose coefficient, annual exposure of workers to 300 Bq m-3 corresponds to 4 mSv. For comparison, using the same coefficient for exposures in homes, 300 Bq m-3 corresponds to 14 mSv. If circumstances of occupational exposure warrant more detailed consideration and reliable alternative data are available, site-specific doses can be assessed using methodology provided in ICRP Publication 137.
Collapse
Affiliation(s)
- J D Harrison
- Public Health England, Centre for Radiation, Chemical and Environmental Hazards, Chilton, Didcot, Oxon OX11 0RQ, UK.,Faculty of Health and Life Sciences, Oxford Brookes University, Oxford OX3 0BP, UK; e-mail:
| | - J W Marsh
- Public Health England, Centre for Radiation, Chemical and Environmental Hazards, Chilton, Didcot, Oxon OX11 0RQ, UK
| |
Collapse
|
4
|
Birchall A, Marsh JW. The Mayak Worker Dosimetry System (MWDS-2013): How to Weight the Absorbed Dose to Different Lung Regions in the Calculation of Lung Dose. Radiat Prot Dosimetry 2017; 176:95-101. [PMID: 27986962 DOI: 10.1093/rpd/ncw245] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/10/2016] [Revised: 07/21/2016] [Accepted: 08/01/2016] [Indexed: 06/06/2023]
Abstract
In the Mayak Worker Dosimetry System-2013, lung dose is calculated as an average of the three absorbed doses to the bronchial, the bronchiolar and the alveolar regions. Previous epidemiological studies involving Mayak Workers have used a lung dose calculated as the total energy deposited in the lungs divided by the mass. These two definitions lead to very different estimates of lung dose, especially for radon dosimetry. This paper uses the results of recent epidemiological studies to justify the use of a regionally weighted lung dose (wi = 1/3, I = 1, 3) over the use of an 'average lung' dose.
Collapse
Affiliation(s)
- A Birchall
- Global Dosimetry Ltd., 1 Macdonald Close, Didcot, Oxon OX11 7BH, UK
| | - J W Marsh
- Radiation Hazards and Emergencies, Centre for Radiation, Chemical and Environmental Hazards, Public Health England, Chilton, DidcotOX11 0RQ, UK
| |
Collapse
|
5
|
Etherington G, Bérard P, Blanchardon E, Breustedt B, Castellani CM, Challeton-de Vathaire C, Giussani A, Franck D, Lopez MA, Marsh JW, Nosske D. TECHNICAL RECOMMENDATIONS FOR MONITORING INDIVIDUALS FOR OCCUPATIONAL INTAKES OF RADIONUCLIDES. Radiat Prot Dosimetry 2016; 170:8-12. [PMID: 26464525 DOI: 10.1093/rpd/ncv395] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/05/2023]
Abstract
The TECHREC project, funded by the European Commission, will provide Technical Recommendations for Monitoring Individuals for Occupational Intakes of Radionuclides It is expected that the document will be published by the European Commission as a report in its Radiation Protection Series during 2016. The project is coordinated by the European Radiation Dosimetry Group (EURADOS) and is being carried out by members of EURADOS Working Group 7 (Internal Dosimetry). This paper describes the aims and purpose of the Technical Recommendations, and explains how the project is organised.
Collapse
Affiliation(s)
- G Etherington
- Public Health England (PHE), Centre for Radiation Chemical and Environmental Hazards, Didcot, UK
| | - P Bérard
- Commissariat à l'Énergie Atomique et aux Énergies Alternatives (CEA), France
| | - E Blanchardon
- Institut de Radioprotection et de Sûreté Nucléaire (IRSN), France
| | - B Breustedt
- Karlsruhe Institute of Technology (KIT), Germany
| | - C M Castellani
- Agenzia nazionale per le nuove tecnologie, l'energia e lo sviluppo economico sostenibile (ENEA), Italy
| | | | - A Giussani
- Bundesamt für Strahlenschutz (BfS), Germany
| | - D Franck
- Institut de Radioprotection et de Sûreté Nucléaire (IRSN), France
| | - M A Lopez
- Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT), Spain
| | - J W Marsh
- Public Health England (PHE), Centre for Radiation Chemical and Environmental Hazards, Didcot, UK
| | - D Nosske
- Bundesamt für Strahlenschutz (BfS), Germany
| |
Collapse
|
6
|
Castellani CM, Marsh JW, Hurtgen C, Blanchardon E, Bérard P, Giussani A, Lopez MA. EURADOS-IDEAS GUIDELINES (VERSION 2) FOR THE ESTIMATION OF COMMITTED DOSES FROM INCORPORATION MONITORING DATA. Radiat Prot Dosimetry 2016; 170:17-20. [PMID: 26541189 DOI: 10.1093/rpd/ncv457] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/05/2023]
Abstract
Dose assessment after intakes of radionuclides requires application of biokinetic and dosimetric models and assumptions about factors influencing the final result. In 2006, a document giving guidance for such assessment was published, commonly referred to as the IDEAS Guidelines. Following its publication, a working group within the European networks CONRAD and EURADOS was established to improve and update the IDEAS Guidelines. This work resulted in Version 2 of the IDEAS Guidelines, which was published in 2013 in the form of a EURADOS report. The general structure of the original document was maintained; however, new procedures were included, e.g. the direct dose assessment method for (3)H or special procedure for wound cases applying the NCRP wound model. In addition, information was updated and expanded, e.g. data on dietary excretion of U, Th, Ra and Po for urine and faeces or typical and achievable values for detection limits for different bioassay measurement techniques.
Collapse
Affiliation(s)
- C M Castellani
- ENEA, Radiation Protection Institute, Via dei Colli 16, 40136 Bologna, Italy
| | - J W Marsh
- Public Health England, Center for Radiation Chemical and Environmental Hazards, Chilton, Didcot, Oxon OX11 0RQ, UK
| | - C Hurtgen
- SCK CEN, Belgian Nuclear Research Centre, Boeretang 200, 2400 Mol, Belgium
| | - E Blanchardon
- Institut de Radioprotection et de Sûreté Nucléaire (IRSN) PRP-HOM/SDI/LEDI, BP17, F-92262 Fontenay-aux-Roses, France
| | - P Bérard
- CEA/Direction des Sciences du Vivant/Unité Prositon, Route du Panorama BP 6, F-92262 Fontenay-aux-RosesCedex, France
| | - A Giussani
- Federal Office for Radiation Protection, Ingolstädter Landstr. 1, 85764 Oberschleißheim, Germany
| | - M A Lopez
- CIEMAT, Centro de Investigaciones Energéticas Medioambientales y Tecnológicas, Avda. Complutense 40, 28040 Madrid, Spain
| |
Collapse
|
7
|
Fontes P, Lopez R, van der Plaats A, Vodovotz Y, Minervini M, Scott V, Soltys K, Shiva S, Paranjpe S, Sadowsky D, Barclay D, Zamora R, Stolz D, Demetris A, Michalopoulos G, Marsh JW. Liver preservation with machine perfusion and a newly developed cell-free oxygen carrier solution under subnormothermic conditions. Am J Transplant 2015; 15:381-94. [PMID: 25612645 PMCID: PMC5024042 DOI: 10.1111/ajt.12991] [Citation(s) in RCA: 97] [Impact Index Per Article: 10.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/12/2014] [Revised: 07/28/2014] [Accepted: 08/23/2014] [Indexed: 01/25/2023]
Abstract
We describe a new preservation modality combining machine perfusion (MP) at subnormothermic conditions(21 °C) with a new hemoglobin-based oxygen carrier (HBOC) solution. MP (n=6) was compared to cold static preservation (CSP; n=6) in porcine orthotopic liver transplants after 9 h of cold ischemia and 5-day follow-up. Recipients' peripheral blood, serial liver biopsies, preservation solutions and bile specimens were collected before, during and after liver preservation. Clinical laboratorial and histological analyses were performed in addition to mitochondrial functional assays, transcriptomic, metabolomic and inflammatory inflammatory mediator analyses. Compared with CSP, MP animals had: (1) significantly higher survival (100%vs. 33%; p<0.05); (2) superior graft function (p<0.05);(3) eight times higher hepatic O2 delivery than O2 consumption (0.78 mL O2/g/h vs. 0.096 mL O2/g/h) during MP; and (4) significantly greater bile production (MP=378.5 ± 179.7; CS=151.6 ± 116.85). MP downregulated interferon (IFN)-α and IFN-γ in liver tissue. MP allografts cleared lactate, produced urea, sustained gluconeogenesis and produced hydrophilic bile after reperfusion. Enhanced oxygenation under subnormothermic conditions triggers regenerative and cell protective responses resulting in improved allograft function. MP at 21 °C with the HBOC solution significantly improves liver preservation compared to CSP.
Collapse
Affiliation(s)
- P. Fontes
- Department of SurgeryUniversity of Pittsburgh Medical CenterPittsburghPA,Department of SurgeryThomas E. Starzl Transplantation InstitutePittsburghPA,McGowan Institute of Regenerative MedicineUniversity of PittsburghPittsburghPA,Department of SurgeryUniversity of PittsburghPittsburghPA
| | - R. Lopez
- Department of SurgeryUniversity of Pittsburgh Medical CenterPittsburghPA,Department of SurgeryThomas E. Starzl Transplantation InstitutePittsburghPA
| | | | - Y. Vodovotz
- Department of SurgeryUniversity of PittsburghPittsburghPA
| | - M. Minervini
- Department of PathologyUniversity of Pittsburgh Medical CenterPittsburghPA
| | - V. Scott
- Department of AnesthesiaUniversity of PittsburghPittsburghPA
| | - K. Soltys
- Department of SurgeryUniversity of Pittsburgh Medical CenterPittsburghPA,Department of SurgeryThomas E. Starzl Transplantation InstitutePittsburghPA
| | - S. Shiva
- Vascular Medicine InstituteDepartment of Cardiothoracic SurgeryUniversity of PittsburghPittsburghPA
| | - S. Paranjpe
- Department of PathologyUniversity of PittsburghPittsburghPA
| | - D. Sadowsky
- Department of SurgeryUniversity of PittsburghPittsburghPA
| | - D. Barclay
- Department of SurgeryUniversity of PittsburghPittsburghPA
| | - R. Zamora
- Department of SurgeryUniversity of PittsburghPittsburghPA
| | - D. Stolz
- Department of PathologyUniversity of PittsburghPittsburghPA
| | - A. Demetris
- Department of PathologyUniversity of Pittsburgh Medical CenterPittsburghPA,Thomas E. Starzl Transplantation InstitutePittsburghPA
| | - G. Michalopoulos
- Department of PathologyUniversity of Pittsburgh Medical CenterPittsburghPA
| | - J. W. Marsh
- Department of SurgeryUniversity of Pittsburgh Medical CenterPittsburghPA,Department of SurgeryThomas E. Starzl Transplantation InstitutePittsburghPA
| |
Collapse
|
8
|
Kreuzer M, Dufey F, Laurier D, Nowak D, Marsh JW, Schnelzer M, Sogl M, Walsh L. Mortality from internal and external radiation exposure in a cohort of male German uranium millers, 1946–2008. Int Arch Occup Environ Health 2014; 88:431-41. [DOI: 10.1007/s00420-014-0973-2] [Citation(s) in RCA: 43] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/17/2014] [Accepted: 08/11/2014] [Indexed: 11/30/2022]
|
9
|
Gregoratto D, Marsh JW. Note on the autocorrelation coefficient as a test statistic for assessment of the goodness-of-fit of biokinetic models to multiple bioassay data sets. Radiat Prot Dosimetry 2013; 157:442-445. [PMID: 23813614 DOI: 10.1093/rpd/nct160] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/02/2023]
Abstract
The European Commission project IDEAS has produced guidelines for internal dose assessments from monitoring data. A key stage in the guidelines requires assessment of the goodness-of-fit of biokinetic models to bioassay data. The present note extends the use of an autocorrelation coefficient to assess the fits of multiple types of bioassay quantity simultaneously.
Collapse
Affiliation(s)
- D Gregoratto
- Centre for Radiation, Chemical and Environmental Hazards, Health Protection Agency, Harwell Campus, Oxon OX11 0RQ, UK
| | | |
Collapse
|
10
|
Abstract
The International Commission on Radiological Protection (ICRP) Publication 66 Human Respiratory Tract Model (HRTM) treats clearance of materials from the respiratory tract as a competitive process between absorption into blood and particle transport to the alimentary tract and lymphatics. The ICRP recommended default absorption rates for lead and polonium (Type M) in ICRP Publication 71 but stated that the values were not appropriate for short-lived radon progeny. This paper reviews and evaluates published data from volunteer and laboratory animal experiments to estimate the HRTM absorption parameter values for short-lived radon progeny. Animal studies showed that lead ions have two phases of absorption: ∼10 % absorbed with a half-time of ∼15 min, the rest with a half-time of ∼10 h. The studies also indicated that some of the lead ions were bound to respiratory tract components. Bound fractions, f(b), for lead were estimated from volunteer and animal studies and ranged from 0.2 to 0.8. Based on the evaluations of published data, the following HRTM absorption parameter values were derived for lead as a decay product of radon: f(r) = 0.1, s(r) = 100 d(-1), s(s) = 1.7 d(-1), f(b) = 0.5 and s(b) = 1.7 d(-1). Effective doses calculated assuming these absorption parameter values instead of a single absorption half-time of 10 h with no binding (as has generally been assumed) are only a few per cent higher. However, as there is some conflicting evidence on the absorption kinetics for radon progeny, dose calculations have been carried out for different sets of absorption parameter values derived from different studies. The results of these calculations are discussed.
Collapse
Affiliation(s)
- J W Marsh
- Centre Radiation, Chemical & Environmental Hazards, Public Health England Chilton, Oxfordshire OX11 0RQ, UK
| | | |
Collapse
|
11
|
Cardinal JS, Reddy SK, Tsung A, Marsh JW, Geller DA. Laparoscopic major hepatectomy: pure laparoscopic approach versus hand-assisted technique. J Hepatobiliary Pancreat Sci 2013; 20:114-9. [PMID: 23053353 DOI: 10.1007/s00534-012-0553-3] [Citation(s) in RCA: 36] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 02/07/2023]
Abstract
Laparoscopic liver resections are being performed with increasing frequency, with several groups having reported minimally invasive approaches for major anatomic hepatic resections. Some surgeons favor a pure laparoscopic approach, while others prefer a hand-assisted approach for major laparoscopic liver resections. There are clear advantages and disadvantages to a hand-assisted technique. The purpose of this study is to summarize the literature comparing pure laparoscopic and hand-assisted approaches for minimally invasive hepatic resection, and to describe our approach in 432 laparoscopic liver resections.
Collapse
Affiliation(s)
- J S Cardinal
- University of Pittsburgh Medical Center, Liver Cancer Center, 3459 Fifth Avenue, Pittsburgh, PA 15213, USA
| | | | | | | | | |
Collapse
|
12
|
Abstract
Currently, the International Commission on Radiological Protection (ICRP) uses the dose conversion convention to calculate effective dose per unit exposure to radon and its progeny. In a recent statement, ICRP indicated the intention that, in future, the same approach will be applied to intakes of radon and its progeny as is applied to all other radionuclides, calculating effective dose using reference biokinetic and dosimetric models, and radiation and tissue weighting factors. Effective dose coefficients will be given for reference conditions of exposure. In this paper, preliminary results of dose calculations for Rn-222 progeny are presented and compared with values obtained using the dose conversion convention. Implications for the setting of reference levels are also discussed.
Collapse
Affiliation(s)
- J D Harrison
- Health Protection Agency, Centre for Radiation, Chemical and Environmental Hazards, Chilton, Didcot, Oxon OX11 0RQ, UK.
| | | |
Collapse
|
13
|
Marsh JW, Blanchardon E, Gregoratto D, Hofmann W, Karcher K, Nosske D, Tomásek L. Dosimetric calculations for uranium miners for epidemiological studies. Radiat Prot Dosimetry 2012; 149:371-383. [PMID: 21816722 DOI: 10.1093/rpd/ncr310] [Citation(s) in RCA: 36] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/31/2023]
Abstract
Epidemiological studies on uranium miners are being carried out to quantify the risk of cancer based on organ dose calculations. Mathematical models have been applied to calculate the annual absorbed doses to regions of the lung, red bone marrow, liver, kidney and stomach for each individual miner arising from exposure to radon gas, radon progeny and long-lived radionuclides (LLR) present in the uranium ore dust and to external gamma radiation. The methodology and dosimetric models used to calculate these organ doses are described and the resulting doses for unit exposure to each source (radon gas, radon progeny and LLR) are presented. The results of dosimetric calculations for a typical German miner are also given. For this miner, the absorbed dose to the central regions of the lung is dominated by the dose arising from exposure to radon progeny, whereas the absorbed dose to the red bone marrow is dominated by the external gamma dose. The uncertainties in the absorbed dose to regions of the lung arising from unit exposure to radon progeny are also discussed. These dose estimates are being used in epidemiological studies of cancer in uranium miners.
Collapse
Affiliation(s)
- J W Marsh
- Health Protection Agency, Radiation Protection Division, Chilton, Didcot, UK.
| | | | | | | | | | | | | |
Collapse
|
14
|
Kreuzer M, Straif K, Marsh JW, Dufey F, Grosche B, Nosske D, Sogl M. Occupational dust and radiation exposure and mortality from stomach cancer among German uranium miners, 1946-2003. Occup Environ Med 2011; 69:217-23. [PMID: 22172952 DOI: 10.1136/oemed-2011-100051] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/13/2022]
Abstract
OBJECTIVES 'Dusty occupations' and exposure to low-dose radiation have been suggested as potential risk factors for stomach cancer. Data from the German uranium miner cohort study are used to further evaluate this topic. METHODS The cohort includes 58 677 miners with complete information on occupational exposure to dust, arsenic and radiation dose based on a detailed job-exposure matrix. A total of 592 stomach cancer deaths occurred in the follow-up period from 1946 to 2003. A Poisson regression model stratified by age and calendar year was used to calculate the excess relative risk (ERR) per unit of cumulative exposure to fine dust or from cumulative absorbed dose to stomach from α or low-LET (low linear energy transfer) radiation. For arsenic exposure, a binary quadratic model was applied. RESULTS After adjustment for each of the three other variables, a statistically non-significant linear relationship was observed for absorbed dose from low-LET radiation (ERR/Gy=0.30, 95% CI -1.26 to 1.87), α radiation (ERR/Gy=22.5, 95% CI -26.5 to 71.5) and fine dust (ERR/dust-year=0.0012, 95% CI -0.0020 to 0.0043). The relationship between stomach cancer and arsenic exposure was non-linear with a 2.1-fold higher RR (95% CI 0.9 to 3.3) in the exposure category above 500 compared with 0 dust-years. CONCLUSION Positive statistically non-significant relationships between stomach cancer and arsenic dust, fine dust and absorbed dose from α and low-LET radiation were found. Overall, low statistical power due to low doses from radiation and dust are of concern.
Collapse
Affiliation(s)
- M Kreuzer
- Department of Radiation Protection and Health, Federal Office for Radiation Protection, Neuherberg, Germany.
| | | | | | | | | | | | | |
Collapse
|
15
|
Lopez MA, Balásházy I, Bérard P, Blanchardon E, Breustedt B, Broggio D, Castellani CM, Franck D, Giussani A, Hurtgen C, James AC, Klein W, Kramer GH, Li WB, Marsh JW, Malatova I, Nosske D, Oeh U, Pan G, Puncher M, Peixoto Telles P, Schimmelpfeng J, Vrba T. EURADOS coordinated action on research, quality assurance and training of internal dose assessments. Radiat Prot Dosimetry 2011; 144:349-352. [PMID: 21156780 DOI: 10.1093/rpd/ncq435] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/30/2023]
Abstract
EURADOS working group on 'Internal Dosimetry (WG7)' represents a frame to develop activities in the field of internal exposures as coordinated actions on quality assurance (QA), research and training. The main tasks to carry out are the update of the IDEAS Guidelines as a reference document for the internal dosimetry community, the implementation and QA of new ICRP biokinetic models, the assessment of uncertainties related to internal dosimetry models and their application, the development of physiology-based models for biokinetics of radionuclides, stable isotope studies, biokinetic modelling of diethylene triamine pentaacetic acid decorporation therapy and Monte-Carlo applications to in vivo assessment of intakes. The working group is entirely supported by EURADOS; links are established with institutions such as IAEA, US Transuranium and Uranium Registries (USA) and CEA (France) for joint collaboration actions.
Collapse
Affiliation(s)
- M A Lopez
- Departamento de Medio Ambiente, CIEMAT, Dosimetría Interna, Avda Complutense 22, 28040 Madrid, Spain.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
16
|
Castellani CM, Lopez MA, Luciani A, Marsh JW, Vrba T, Cruz-Suarez R. Results of an internal dose assessment intercomparison exercise after a EURADOS/IAEA training course. Radiat Prot Dosimetry 2011; 144:592-595. [PMID: 21051435 DOI: 10.1093/rpd/ncq344] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/30/2023]
Abstract
A training course named 'European Radiation Dosimetry Group/International Atomic Energy Agency Advanced Training Course on Internal Dose Assessment' was held in Czech Technical University in Prague from 2 to 6 February 2009. The course, jointly organised by the two organisations, had the aim of providing guidance on the application of IDEAS guidelines and of disseminating the results of EC CONRAD Project in relation to internal dosimetry (Work Package 5). At the end of the course a dose assessment exercise was proposed to participants. Four artificial cases, named exercises left to participants, were used to check the capabilities of application of the IDEAS guidelines, gained by participants during the event. The participants had to use both hand calculations and dedicated software, in limited time (7 h). Forty per cent of participants had solved all four cases in the allotted time. The results of the dose assessment were analysed to gain experience in types of errors assessors may make during the evaluations. The result of this intercomparison exercise was promising: half of the results in each case were equal to the 'reference evaluation estimate', which was obtained by applying the guidelines correctly.
Collapse
Affiliation(s)
- C-M Castellani
- ENEA, Radiation Protection Institute, Via dei Colli 16, 40136 Bologna, Italy.
| | | | | | | | | | | |
Collapse
|
17
|
Gregoratto D, Bailey MR, Marsh JW. Particle clearance in the alveolar-interstitial region of the human lungs: model validation. Radiat Prot Dosimetry 2011; 144:353-356. [PMID: 21036808 DOI: 10.1093/rpd/ncq314] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/30/2023]
Abstract
New information on particle retention of inhaled insoluble material indicates that the ICRP Human Respiratory Tract Model (HRTM) significantly underestimates long-term retention in the lungs. In a previous paper, the information from three studies was reviewed, and a model developed to predict particle retention in the lungs of coal miners was adapted in order to obtain parameter values for general use to predict particle retention in the alveolar-interstitial (AI) region. The model is physiologically based and simpler than the HRTM, requiring two instead of three compartments to model the AI region. The main difference from the HRTM AI model is that a significant fraction, about 35 %, of the AI deposit of insoluble material remains sequestered in the interstitium. The new model is here applied to the analysis of two well-known contamination cases with several years of follow-up data.
Collapse
Affiliation(s)
- D Gregoratto
- Radiation Protection Division, Health Protection Agency, Chilton, Didcot, Oxon OX11 0RQ, UK.
| | | | | |
Collapse
|
18
|
Gruttadauria S, Saint Georges Chaumet M, Pagano D, Marsh JW, Bartoccelli C, Gridelli BG. Effect of blood transfusion on early outcome of liver resection for colorectal hepatic metastases. J Clin Oncol 2011. [DOI: 10.1200/jco.2011.29.4_suppl.314] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
314 Background: The useof intraoperative blood transfusions (IBT) has been associated with worse surgical outcome in patients undergoing liver resection for malignancy. However, detailed analyses are required to define clinical findings impacting short-term outcome in this scenario.The aim of this study is to evaluate whether IBT are associated with a worse short-term outcome of liver resection in patients with colorectal hepatic metastases, and to assess whether certain patient characteristics and/or surgical variables affect the need for IBT. Methods: In a series of 127 consecutive patients who underwent partial liver resection for colorectal metastases, between July 1999 and March 2010, we studied postoperative 90 days surgical outcome relative to IBT, and the effect of a variety of factors, including type of resection, surgical technique used, concomitant colo-rectal resection, non-tumoral hepatic histological findings, site of primary tumor, and comorbidities, on the incidence of IBT. Results: Patients who received IBT during their liver resection were more likely to have a longer postoperative length of stay (p = 0.02), to experience complications (p = 0.0003), and to experience a Clavien Grade IIIa or worse complication (p = 0.003). Furthermore, undergoing a major resection, and the presence of portal fibrosis in the non-tumoral liver were both correlated with an increase in IBT (respectively, p = 0.003 and p = 0.049), while the surgical technique used (Kellyclasia or TissueLink), the presence of steatosis, undergoing a concomitant major colonic or rectal resection, and having a major comorbidity had no effect on the incidence of IBT (p ≥ 0.05). Conclusions: This study confirmed that receiving IBT during partial liver resection for colorectal hepatic metastases is associated with a worse short-term surgical outcome. These clinical findings suggest that although several significant factors (surgical technique chosen, comorbidities present, etc.) do not seem to influence the short-term outcome of surgery, it is important to be aware of the deleterious effects of the type of resection performed and the presence of portal fibrosis on blood loss during partial liver resection. No significant financial relationships to disclose.
Collapse
Affiliation(s)
- S. Gruttadauria
- Istituto Mediterraneo Trapianti e Terapie ad Alta Specializzazione, University of Pittsburgh Medical Center in Italy, Palermo, Italy; School of Medicine, University of Pittsburgh, Pittsburgh, PA; University of Pittsburgh Medical Center Neuroendocrine Cancer Treatment Center, Pittsburgh, PA
| | - M. Saint Georges Chaumet
- Istituto Mediterraneo Trapianti e Terapie ad Alta Specializzazione, University of Pittsburgh Medical Center in Italy, Palermo, Italy; School of Medicine, University of Pittsburgh, Pittsburgh, PA; University of Pittsburgh Medical Center Neuroendocrine Cancer Treatment Center, Pittsburgh, PA
| | - D. Pagano
- Istituto Mediterraneo Trapianti e Terapie ad Alta Specializzazione, University of Pittsburgh Medical Center in Italy, Palermo, Italy; School of Medicine, University of Pittsburgh, Pittsburgh, PA; University of Pittsburgh Medical Center Neuroendocrine Cancer Treatment Center, Pittsburgh, PA
| | - J. W. Marsh
- Istituto Mediterraneo Trapianti e Terapie ad Alta Specializzazione, University of Pittsburgh Medical Center in Italy, Palermo, Italy; School of Medicine, University of Pittsburgh, Pittsburgh, PA; University of Pittsburgh Medical Center Neuroendocrine Cancer Treatment Center, Pittsburgh, PA
| | - C. Bartoccelli
- Istituto Mediterraneo Trapianti e Terapie ad Alta Specializzazione, University of Pittsburgh Medical Center in Italy, Palermo, Italy; School of Medicine, University of Pittsburgh, Pittsburgh, PA; University of Pittsburgh Medical Center Neuroendocrine Cancer Treatment Center, Pittsburgh, PA
| | - B. G. Gridelli
- Istituto Mediterraneo Trapianti e Terapie ad Alta Specializzazione, University of Pittsburgh Medical Center in Italy, Palermo, Italy; School of Medicine, University of Pittsburgh, Pittsburgh, PA; University of Pittsburgh Medical Center Neuroendocrine Cancer Treatment Center, Pittsburgh, PA
| |
Collapse
|
19
|
Cho SW, Steel J, Tsung A, Marsh JW, Geller DA, Gamblin TC. Safety of liver resection in the elderly: how important is age? Ann Surg Oncol 2010; 18:1088-95. [PMID: 21046265 DOI: 10.1245/s10434-010-1404-6] [Citation(s) in RCA: 45] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/05/2010] [Indexed: 12/15/2022]
Abstract
BACKGROUND With the aging population, more elderly patients are being considered for hepatic resection. We investigated whether advanced age was associated with higher rate and severity of postoperative complications. METHODS A total of 75 patients aged ≥70 years (group E) were matched with 75 patients aged <70 years (group Y) by the extent of liver resection and by operative indications. Primary outcome measures were rates and severity of complications. Secondary outcome measures were length of hospital stay and discharge destination. Univariate analysis was also performed to identify variables associated with higher surgical risk. RESULTS Male-to-female ratio was 43:32 in both groups. Overall complication rates were 44 and 33.3% in group E and Y, respectively (P = 0.241; odds ratio = 1.57; 95% confidence interval [95% CI], 0.81-3.05). There was no mortality in both groups. The only postoperative age-related morbidity was confusion in the elderly. There was no difference in the rates of severe complications (grade ≥3) between group E and group Y (16 vs. 14.7%; P = 0.744; odds ratio = 1.11; 95% CI, 0.46-2.70). Median length of hospital stay were 7 and 6 days, respectively (P = 0.01). Nineteen percent and 1% of patients in group E and group Y were discharge to rehabilitation facilities, respectively (P = 0.001). Univariate analysis showed that preoperative systemic chemotherapy and longer operative time were associated with higher morbidity in the elderly. CONCLUSIONS Liver resection can be performed in patients aged ≥70 years as safely as in younger patients. Duration and timing of systemic chemotherapy before liver resection should be optimized to minimize postoperative morbidity.
Collapse
Affiliation(s)
- S W Cho
- UPMC Liver Cancer Center, University of Pittsburgh Medical Center, Pittsburgh, PA, USA
| | | | | | | | | | | |
Collapse
|
20
|
Abstract
Better information is available now on long-term particle retention in the human lungs than there was in 1994, when the human respiratory tract model (HRTM) was adopted by the International Commission on Radiological Protection (ICRP). Three recent studies are especially useful because they provide such information for groups of people who inhaled very similar aerosols. For all three the HRTM significantly underestimates lung retention of insoluble material. The purpose of this work was to improve the modelling of long-term retention in the deep lung. A simple physiologically based model developed to predict lung and lymph node particle retention in coal miners was found to represent lung retention in these studies adequately. Instead of the three alveolar-interstitial (AI) compartments in the HRTM, it has an alveolar compartment which clears to the bronchial tree and to a second compartment, representing the interstitium, which clears only to lymph nodes. The main difference from the HRTM AI model is that a significant fraction of the AI deposit is sequestered in the interstitium. To obtain default parameter values for general use, the model was fitted to data from the three recent studies, and also the experimental data used in development of the HRTM to define particle transport from the AI region for the first year after intake. The result of the analysis is that about 40% of the AI deposit of insoluble particles is sequestered in the interstitium and the remaining fraction is cleared to the ciliated airways with a half-time of about 300 days. For some long-lived radionuclides in relatively insoluble form (type S), this increased retention increases the lung dose per unit intake by 50-100% compared to the HRTM value.
Collapse
Affiliation(s)
- D Gregoratto
- Centre for Radiation, Chemical and Environmental Hazards, Health Protection Agency, Chilton, Didcot, Oxon, UK.
| | | | | |
Collapse
|
21
|
Gruttadauria S, di Francesco F, Li Petri S, Dominioni T, Lorenzin D, Cintorino D, Spada M, Marsh JW, Marcos A, Gridelli B. Technical aspects of living-related liver donation: single-center experience. Transplant Proc 2009; 41:1273-4. [PMID: 19460536 DOI: 10.1016/j.transproceed.2009.03.012] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
Abstract
Living-related donor liver transplantation is the newest and both technically and ethically most challenging evolution in liver transplantation and has contributed to reduction in donor shortage. We briefly report the technical aspects of surgical procedures performed to achieve a partial graft from a live donor. Eighty-four adult and two pediatric recipients underwent living-related donor liver transplantation at our center. There were no donor deaths, and all patients returned to their normal activities after the perioperative period. This single-center experience may contribute to refinement of the surgical technique required to improve the outcome of these complex operations.
Collapse
Affiliation(s)
- S Gruttadauria
- Istituto Mediterraneo Trapianti e Terapie ad Alta Specializzazione-University of Pittsburgh Medical Center, Palermo, Italy.
| | | | | | | | | | | | | | | | | | | |
Collapse
|
22
|
de Vera ME, Lopez-Solis R, Dvorchik I, Campos S, Morris W, Demetris AJ, Fontes P, Marsh JW. Liver transplantation using donation after cardiac death donors: long-term follow-up from a single center. Am J Transplant 2009; 9:773-81. [PMID: 19344466 DOI: 10.1111/j.1600-6143.2009.02560.x] [Citation(s) in RCA: 235] [Impact Index Per Article: 15.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/25/2023]
Abstract
There is a lack of universally accepted clinical parameters to guide the utilization of donation after cardiac death (DCD) donor livers and it is unclear as to which patients would benefit most from these organs. We reviewed our experience in 141 patients who underwent liver transplantation using DCD allografts from 1993 to 2007. Patient outcomes were analyzed in comparison to a matched cohort of 282 patients who received livers from donation after brain death (DBD) donors. Patient survival was similar, but 1-, 5- and 10-year graft survival was significantly lower in DCD (69%, 56%, 44%) versus DBD (82%, 73%, 63%) subjects (p < 0.0001). Primary nonfunction and biliary complications were more common in DCD patients, accounting for 67% of early graft failures. A donor warm ischemia time >20 min, cold ischemia time >8 h and donor age >60 were associated with poorer DCD outcomes. There was a lack of survival benefit in DCD livers utilized in patients with model for end-stage liver disease (MELD) < or =30 or those not on organ-perfusion support, as graft survival was significantly lower compared to DBD patients. However, DCD and DBD subjects transplanted with MELD >30 or on organ-perfusion support had similar graft survival, suggesting a potentially greater benefit of DCD livers in critically ill patients.
Collapse
Affiliation(s)
- M E de Vera
- Thomas E. Starzl Transplantation Institute, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
| | | | | | | | | | | | | | | |
Collapse
|
23
|
Cho SW, Marsh JW, Geller DA, Holtzman M, Zeh H, Bartlett DL, Gamblin TC. Surgical management of leiomyosarcoma of the inferior vena cava. J Gastrointest Surg 2008; 12:2141-8. [PMID: 18841423 DOI: 10.1007/s11605-008-0700-y] [Citation(s) in RCA: 41] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/20/2008] [Accepted: 09/08/2008] [Indexed: 01/31/2023]
Abstract
INTRODUCTION Leiomyosarcoma of the inferior vena cava (IVC) is a rare tumor for which en bloc resection offers the only chance of cure. Due to its rarity, however, optimal strategies for the management of the primary tumor and subsequent recurrences are not well defined. METHODS We performed a retrospective review of patients who underwent surgical resection of IVC leiomyosarcoma. We evaluated clinical presentations, operative techniques, patterns of recurrence and survival. RESULTS From 1990 to 2008, nine patients (four females) were identified. Median age was 55 years (40-76). Presentations included abdominal pain (n = 5), back pain (n = 2), leg swelling (n = 4) and abdominal mass (n = 2). Pre-operative imaging studies showed tumor location to be from the right atrium to renal veins (n = 1), retrohepatic (n = 5), and from hepatic veins to the iliac bifurcations (n = 3). En bloc resection included right nephrectomy (n = 5), right adrenalectomy (n = 4), pancreaticoduodenectomy (n = 1), right hepatic trisectionectomy (n = 1) and right hemicolectomy (n = 1). The IVC was ligated in six patients, and a prosthetic graft was used for IVC reconstruction in three patients. Resection margins were negative in seven cases. Median length of stay was 12 days (range, 6-22 days). Major morbidity included renal failure (n = 1) and there was one post-operative mortality. Five patients had leg edema post-operatively, four of whom had IVC ligation. Median survival was 47 months (range, 1-181 months). Four patients had recurrence and the median time to recurrence was 14 months (range, 3-25 months). Two patients underwent successful resection of recurrence. CONCLUSIONS Curative resection of IVC leiomyosarcoma can lead to long-term survival. However, recurrence is common, and effective adjuvant treatments are needed. In selected cases, aggressive surgical treatment of recurrence should be considered.
Collapse
Affiliation(s)
- S W Cho
- Department of Surgery, University of Pittsburgh, Pittsburgh, PA, USA
| | | | | | | | | | | | | |
Collapse
|
24
|
Lopez MA, Etherington G, Castellani CM, Franck D, Hurtgen C, Marsh JW, Nosske D, Breustedt B, Blanchardon E, Andrasi A, Bailey MR, Balashazy I, Battisti P, Bérard P, Birchall A, Broggio D, Challeton-de-Vathaire C, Cruz-Suarez R, Doerfel H, Giussani A, Hodgson A, Koukouliou V, Kramer GH, Le Guen B, Luciani A, Malatova I, Molokanov A, Moraleda M, Muikku M, Oeh U, Puncher M, Rahola T, Stradling N, Vrba T. Internal dosimetry: towards harmonisation and coordination of research. Radiat Prot Dosimetry 2008; 131:28-33. [PMID: 18757895 DOI: 10.1093/rpd/ncn217] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/26/2023]
Abstract
The CONRAD Project is a Coordinated Network for Radiation Dosimetry funded by the European Commission 6th Framework Programme. The activities developed within CONRAD Work Package 5 ('Coordination of Research on Internal Dosimetry') have contributed to improve the harmonisation and reliability in the assessment of internal doses. The tasks carried out included a study of uncertainties and the refinement of the IDEAS Guidelines associated with the evaluation of doses after intakes of radionuclides. The implementation and quality assurance of new biokinetic models for dose assessment and the first attempt to develop a generic dosimetric model for DTPA therapy are important WP5 achievements. Applications of voxel phantoms and Monte Carlo simulations for the assessment of intakes from in vivo measurements were also considered. A Nuclear Emergency Monitoring Network (EUREMON) has been established for the interpretation of monitoring data after accidental or deliberate releases of radionuclides. Finally, WP5 group has worked on the update of the existing IDEAS bibliographic, internal contamination and case evaluation databases. A summary of CONRAD WP5 objectives and results is presented here.
Collapse
Affiliation(s)
- M A Lopez
- CIEMAT, Centro de Investigaciones Energéticas Medioambientales y Tecnologicas, Avda Complutense 22, 28040 Madrid, Spain.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
25
|
Marsh JW, Castellani CM, Hurtgen C, Lopez MA, Andrasi A, Bailey MR, Birchall A, Blanchardon E, Desai AD, Dorrian MD, Doerfel H, Koukouliou V, Luciani A, Malatova I, Molokanov A, Puncher M, Vrba T. Internal dose assessments: uncertainty studies and update of ideas guidelines and databases within CONRAD project. Radiat Prot Dosimetry 2008; 131:34-39. [PMID: 18718961 DOI: 10.1093/rpd/ncn218] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/26/2023]
Abstract
The work of Task Group 5.1 (uncertainty studies and revision of IDEAS guidelines) and Task Group 5.5 (update of IDEAS databases) of the CONRAD project is described. Scattering factor (SF) values (i.e. measurement uncertainties) have been calculated for different radionuclides and types of monitoring data using real data contained in the IDEAS Internal Contamination Database. Based upon this work and other published values, default SF values are suggested. Uncertainty studies have been carried out using both a Bayesian approach as well as a frequentist (classical) approach. The IDEAS guidelines have been revised in areas relating to the evaluation of an effective AMAD, guidance is given on evaluating wound cases with the NCRP wound model and suggestions made on the number and type of measurements required for dose assessment.
Collapse
Affiliation(s)
- J W Marsh
- Health Protection Agency, Radiation Protection Division, Chilton, Didcot, UK.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
26
|
Marsh JW, Bessa Y, Birchall A, Blanchardon E, Hofmann W, Nosske D, Tomasek L. Dosimetric models used in the Alpha-Risk project to quantify exposure of uranium miners to radon gas and its progeny. Radiat Prot Dosimetry 2008; 130:101-106. [PMID: 18456899 DOI: 10.1093/rpd/ncn119] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/26/2023]
Abstract
The European project Alpha-Risk aims to quantify the cancer and non-cancer risks associated with multiple chronic radiation exposures by epidemiological studies, organ dose calculation and risk assessment. In the framework of this project, mathematical models have been applied to the organ dosimetry of uranium miners who are internally exposed to radon and its progeny as well as to long-lived radionuclides present in the uranium ore. This paper describes the methodology and the dosimetric models used to calculate the absorbed doses to specific organs arising from exposure to radon and its progeny in the uranium mines. The results of dose calculations are also presented.
Collapse
Affiliation(s)
- J W Marsh
- Health Protection Agency, Radiation Protection Division, Chilton, Didcot, UK.
| | | | | | | | | | | | | |
Collapse
|
27
|
Bartynski WS, Tan HP, Boardman JF, Shapiro R, Marsh JW. Posterior reversible encephalopathy syndrome after solid organ transplantation. AJNR Am J Neuroradiol 2008; 29:924-30. [PMID: 18272559 DOI: 10.3174/ajnr.a0960] [Citation(s) in RCA: 156] [Impact Index Per Article: 9.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/01/2023]
Abstract
BACKGROUND AND PURPOSE Posterior reversible encephalopathy syndrome (PRES) is known to occur after solid organ transplantation (SOT), potentially associated with cyclosporine and tacrolimus. In this study, we assess the frequency and clinical and imaging characteristics of PRES after SOT. MATERIALS AND METHODS We identified 27 patients (13 men and 14 women; age range, 22-72 years) who developed PRES after SOT. Features noted included SOT subtype, incidence and timing of PRES, infection and rejection, mean arterial pressure (MAP), and toxicity brain edema. RESULTS PRES developed in 21 (0.49%) of 4222 patients who underwent transplantation within the study period (no significant difference among SOT subtypes). Transplantation was performed in 5 patients before the study period, and 1 patient underwent transplantation elsewhere. In consideration of all 27 patients, PRES typically developed in the first 2 months in patients who had SOT of the liver (9 of 10 patients) and was associated with cytomegalovirus (CMV), mild rejection, or systemic bacterial infection. PRES also typically developed after 1 year in patients who had SOT of the kidney (8 of 9 patients) and was associated with moderate rejection or bacterial infection. Toxicity MAP was significantly lower (P < .001) in liver transplants (average MAP, 104.8 +/- 16 mm Hg) compared with that in kidney transplants (average MAP, 143 +/- 20 mm Hg). Toxicity brain edema was significantly greater (P < .001) in patients who had liver transplants and developed PRES compared with patients who had undergone kidney transplants despite severe hypertension in those who had the kidney transplants. CONCLUSION Patients who had undergone SOTs have a similar low incidence of developing PRES. Differences between those who have had liver and kidney transplants included time after transplant, toxicity MAP, and PRES vasogenic edema noted at presentation. In patients who have undergone kidney transplants, severely elevated MAP was associated with reduced, not greater, brain edema.
Collapse
Affiliation(s)
- W S Bartynski
- Department of Radiology, Division of Neuroradiology, University of Pittsburgh, Presbyterian University Hospital, Pittsburgh, PA, USA.
| | | | | | | | | |
Collapse
|
28
|
Marsh JW, Blanchardon E, Castellani CM, Desai AD, Dorrian MD, Hurtgen C, Koukouliou V, Lopez MA, Luciani A, Puncher M, Andrasi A, Bailey MR, Berkovski V, Birchall A, Bonchug Y, Doerfel H, Malatova I, Molokanov A, Ratia H. Evaluation of scattering factor values for internal dose assessment following the IDEAS guidelines: preliminary results. Radiat Prot Dosimetry 2007; 127:339-342. [PMID: 18045799 DOI: 10.1093/rpd/ncm353] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/25/2023]
Abstract
The IDEAS Guidelines for the assessment of internal doses from monitoring data suggest default measurement uncertainties (i.e. scattering factors, SFs) to be used for different types of monitoring data. However, these default values were mainly based upon expert judgement. In this paper, SF values have been calculated for different radionuclides and types of monitoring data using real data contained in the IDEAS Internal Contamination Database. Results are presented.
Collapse
Affiliation(s)
- J W Marsh
- Health Protection Agency, Radiation Protection Division, Chilton, Didcot, UK.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
29
|
Birchall A, Puncher M, Marsh JW. Avoiding biased estimates of dose when nothing is known about the time of intake. Radiat Prot Dosimetry 2007; 127:343-346. [PMID: 18003710 DOI: 10.1093/rpd/ncm286] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/25/2023]
Abstract
A common problem in internal dosimetry occurs in routine monitoring, when it is required to estimate an intake from a measurement made at the end of a monitoring interval, and the time of intake is unknown. ICRP suggests that it should be assumed that the intake occurred in the middle of the monitoring period. However, it has been shown that this will, in the long-term, lead to biased estimates of a worker's intake and dose. In order to overcome this biasing, the United States Department of Energy (USDOE) recommends a different method based on calculating the intakes for all possible intake times in the interval and then taking an arithmetic average. In a recent paper, it has been shown that both the ICRP and USDOE methods were biased and that the only unbiased estimator of the true intake was obtained by assuming a constant chronic intake throughout the monitoring interval. In all of the analyses carried out to date on this 'Constant Chronic' method, it was assumed that the measurements were exact. In this paper, the effects of assuming either normally or log-normally distributed measurement errors are explored, and the effect on the bias of the intake estimate is investigated.
Collapse
Affiliation(s)
- A Birchall
- Radiation Protection Division, HPA Centre for Radiation, Chemical and Environmental Hazards, Chilton, Didcot, Oxon OX11 0RQ, UK.
| | | | | |
Collapse
|
30
|
Youngman MJ, Davis KE, Etherington G, Marsh JW. ERIDAS, a computer program for rapid calculation of internal doses from measurements of people in an emergency. Radiat Prot Dosimetry 2007; 127:374-377. [PMID: 18003709 DOI: 10.1093/rpd/ncm290] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/25/2023]
Abstract
In an emergency involving the deliberate or accidental release of radioactive materials, there could potentially be a large number of people who require monitoring for internal contamination. Doses from these measurements will need to be calculated as quickly as possible. Emergency Response Internal Dose Assessment Software (ERIDAS) has been designed for this purpose.
Collapse
Affiliation(s)
- M J Youngman
- Radiation Protection Division, Health Protection Agency, Chilton, Didcot, Oxfordshire OX11 0RQ, UK.
| | | | | | | |
Collapse
|
31
|
Silveira FP, Husain S, Kwak EJ, Linden PK, Marcos A, Shapiro R, Fontes P, Marsh JW, de Vera M, Tom K, Thai N, Tan HP, Basu A, Soltys K, Paterson DL. Cryptococcosis in liver and kidney transplant recipients receiving anti-thymocyte globulin or alemtuzumab. Transpl Infect Dis 2007; 9:22-7. [PMID: 17313467 DOI: 10.1111/j.1399-3062.2006.00149.x] [Citation(s) in RCA: 64] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Abstract
Rabbit anti-thymocyte globulin (ATG) and alemtuzumab have been used for induction or preconditioning and for the treatment of acute rejection in organ transplant recipients in many centers. Such regimens may lead to a substantial decline in the CD4 lymphocyte count to levels seen in other population groups at high risk of cryptococcosis. In view of this, we examined the impact of such therapy on the cumulative incidence of cryptococcosis among liver and kidney recipients. A total of 834 liver and 727 kidney transplants were performed during the study period. Seven hundred and eighty-one patients did not receive ATG or alemtuzumab; 646 received 1 dose of either drug, and 134 patients received 2 doses of either drug. The cumulative incidence of cryptococcosis was 0.26% (2/781) among those who did not receive ATG or alemtuzumab; 0.3% (2/646) among those who received only 1 dose, and 2.24% (3/134) among those who received 2 doses (P=0.03). There were 5 cases of cryptococcosis in liver recipients and 2 in kidney recipients. There were 3 cases of cryptococcal meningitis, 3 of pneumonia, and 1 of disseminated disease. The 2 kidney recipients had meningitis. Diagnosis occurred at a median of 255 days (range 7-517) after transplantation. The mortality rate was 14.2%. We conclude that the use of 1 dose of ATG or alemtuzumab is not associated with an increased cumulative incidence of cryptococcosis, but that those patients receiving 2 doses are at increased risk.
Collapse
Affiliation(s)
- F P Silveira
- Division of Infectious Diseases, University of Pittsburgh Medical Center, Pittsburgh, PA 15213, USA
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
32
|
Kristóf K, Szabó D, Marsh JW, Cser V, Janik L, Rozgonyi F, Nobilis A, Nagy K, Paterson DL. Extended-spectrum beta-lactamase-producing Klebsiella spp. in a neonatal intensive care unit: risk factors for the infection and the dynamics of the molecular epidemiology. Eur J Clin Microbiol Infect Dis 2007; 26:563-70. [PMID: 17587071 DOI: 10.1007/s10096-007-0338-9] [Citation(s) in RCA: 27] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
Abstract
The extended-spectrum beta-lactamase (ESBL)-producing Klebsiella spp. cause worldwide problems in intensive care units. The aim of this study was to investigate the molecular epidemiology of ESBL-producing Klebsiella pneumoniae and K. oxytoca strains in a neonatal intensive care unit (NICU) in Budapest, Hungary and to determine the risk factors of the infections and the epidemiological features. Infections with Klebsiella spp. were analyzed retrospectively by reviewing the medical records between January 2001 and December 2005. Antibiotic susceptibility tests, isoelectric focusing, pulsed field gel electrophoresis, plasmid analysis, PCR for bla(TEM) and bla(SHV) and DNA sequencing analysis were performed on ESBL-producing Klebsiella isolates. A total of 45 babies were found to be infected with non-ESBL-producing Klebsiella spp. and 39 with ESBL-producing Klebsiella spp. Of the parameters analyzed, including sex, gestational age, twin pregnancy, birth weight, presence of central vascular catheter, mechanical ventilator use, parenteral nutrition, polymicrobial infection, caesarean section, transfusion and mortality, we found no statistically significant difference between the ESBL and the non-ESBL groups, or between the K. pneumoniae and K. oxytoca species. Further characterization of the ESBL-producing K. pneumoniae and K. oxytoca strains isolated between February 2001 and January 2003 revealed three distinct PFGE patterns of SHV-5-producing K. pneumoniae (A, B, E) and two distinct patterns of SHV-12-producing K. oxytoca (C,D) isolates; these had different plasmid profiles. From July to November 2005, a new SHV-5 producing K. oxytoca (F) was isolated. The molecular epidemiology of ESBL-producing organisms in a NICU over time shows substantial shifts in predominant strains. The ESBL production of the infected organisms has an impact on the survival of newborn babies with infections caused by Klebsiella spp.
Collapse
Affiliation(s)
- K Kristóf
- Institute of Medical Microbiology, Semmelweis University, Nagyvárad tér 4, 1089, Budapest, Hungary
| | | | | | | | | | | | | | | | | |
Collapse
|
33
|
Dvorchik I, Demetris AJ, Geller DA, Carr BI, Fontes P, Finkelstein SD, Cappella NK, Marsh JW. Prognostic models in hepatocellular carcinoma (HCC) and statistical methodologies behind them. Curr Pharm Des 2007; 13:1527-32. [PMID: 17504148 DOI: 10.2174/138161207780765846] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
Hepatocellular carcinoma (HCC) is estimated to be responsible for 250,000 deaths worldwide yearly. Aggressive surgical resection or liver transplantation still remain the only viable curative options for patients suffering the disease despite the multitude of emerging therapies for HCC. However, even with the most aggressive surgical intervention, survival varies widely within each particular stage of HCC. In order to improve utilization of available therapeutic modalities, a number of outcome prognostic models have been developed. This manuscript reviews the prognostic models most commonly utilized in clinical practice and the statistical methodologies on which these models are based. A multitude of statistical and mathematical techniques can be used for prognostic model development. The most common methodologies used for HCC prognostic model development can be generally divided into four groups: survival, artificial neural networks, analysis of variance, and cluster analysis. Survival methodologies (such as Cox proportional hazard model) are commonly employed for estimation of relative significance of risk factors for patient survival or cancer recurrence. Artificial neural networks (such as back-propagation network) can be supreme approximation tools for any continuous or binary function, and as such can be employed for prognostication of HCC recurrence (death). Analysis of variance and cluster analysis are the most common statistical tools of recently evolved microarrays technology, which, in turn, is one of the most promising tools available to the cancer researcher.
Collapse
Affiliation(s)
- I Dvorchik
- Department of Surgery, Thomas E. Starzl Transplantation Institute, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USA.
| | | | | | | | | | | | | | | |
Collapse
|
34
|
Davis K, Marsh JW, Gerondal M, Bailey MR, Le Guen B. Assessment of intakes and doses to workers followed for 15 years after accidental inhalation of 60CO. Health Phys 2007; 92:332-44. [PMID: 17351497 DOI: 10.1097/01.hp.0000250618.97979.35] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/14/2023]
Abstract
Intakes and doses are assessed for seven workers who accidentally inhaled particles containing Co in the same incident. Comprehensive whole body data to 15 y, and some early urine and fecal data, are available for each individual. The biokinetic and dosimetric models currently recommended by ICRP have been used to assess these cases. It was not possible to obtain good fits to the data using the ICRP models with their default parameter values. However, good fits to all the measurement data were obtained by varying parameter values following a procedure similar to that recommended in recently developed guidelines for assessment of internal doses from monitoring data. It was found that retention in the lungs was much longer than predicted by the ICRP Human Respiratory Tract Model, and so for each case it was necessary to reduce the particle transport clearance of material from the deep lungs. This reduction in lung clearance rates, and the use of specific AMAD values, were the dominating factors in changing assessed doses from those calculated using ICRP default values.
Collapse
Affiliation(s)
- K Davis
- Radiation Protection Division, Health Protection Agency (HPA), Chilton, Didcot, Oxon OX11 0RQ, UK
| | | | | | | | | |
Collapse
|
35
|
Gruttadauria S, Marsh JW, Cintorino D, Biondo D, Luca A, Arcadipane A, Vizzini G, Volpes R, Marcos A, Gridelli B. Adult to adult living-related liver transplant: report on an initial experience in Italy. Dig Liver Dis 2007; 39:342-50. [PMID: 17337259 DOI: 10.1016/j.dld.2007.01.006] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/25/2006] [Revised: 12/21/2006] [Accepted: 01/09/2007] [Indexed: 02/07/2023]
Abstract
INTRODUCTION Living-related liver transplantation has become the treatment of choice for many liver diseases. We present our initial analysis of 53 cases of adult to adult living-related liver transplantation performed in a single institute in Italy. MATERIALS AND METHODS From January 2002 to September 2006, we performed 53 adult to adult living-related liver transplantations. The donors (age 18-53) all had genetic or emotional relationships; they were all ABO identical or compatible. Recipients (ages 18-68) suffered from cirrhosis secondary to viral etiology (18), hepatocellular carcinoma with viral cirrhosis (24), cystic fibrosis (2), primary biliary cirrhosis (2), hepatocellular carcinoma with non-viral cirrhosis (2), alcoholic cirrhosis (1), ornithine transcarbamylase deficiency (OTC), (1) criptogenic cryptogenic cirrhosis, (1) primary sclerosing cholangitis, (1) biliary atresia and metastatic carcinoid (1). Donor liver resection resulted in 51 right hepatectomies and two left hepatectomies. Graft body weight ratio was always above 0.8%; graft implantation was performed with the piggy back technique and, in 43 cases, with the use of veno-venous bypass. RESULTS There was neither donor mortality nor need of blood transfusion. Actuarial recipient survival rate at 3 years was 82.66% and graft survival rate was 75.34%. Six patients underwent retransplantation: in four cases due to hepatic artery thrombosis, and in two, due to graft dysfunction. Three patients had one episode each of acute cellular rejection. CONCLUSION Adult to adult living-related liver transplantation represents a resource to be used in confronting organ shortage, and is a valuable option for decreasing mortality and drop out from the waiting list.
Collapse
Affiliation(s)
- S Gruttadauria
- Mediterranean Institute for Transplantation and Advanced Specialized Therapies, University of Pittsburgh Medical Center in Italy, Palermo, Italy.
| | | | | | | | | | | | | | | | | | | |
Collapse
|
36
|
Gruttadauria S, Mandalà L, Biondo D, Spampinato M, Lamonaca V, Volpes R, Vizzini G, Marsh JW, Marcos A, Gridelli B. Role of basiliximab in the prevention of acute cellular rejection in adult to adult living-related liver transplantation: a single center experience. Biologics 2007; 1:69-73. [PMID: 19707350 PMCID: PMC2721340] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Abstract
We report our single center experience with the use of basiliximab, a chimeric monoclonal antibody directed against the alpha chain of the interleukin-2 (IL-2) receptor (CD25), in combination with a steroid- and tacrolimus-based regimen in adult to adult living-related liver transplantation (ALRLT). Sixty consecutive ALRLTs were analyzed. All patients received two 20-mg doses of basiliximab (days 0 and 4 after transplantation) followed by tacrolimus (0.15 mg/kg/day; 10-15 ng/mL target trough levels) and a dose regimen of steroids (starting with 20 mg iv, switched to po as soon as the patient was able to eat, and weaned off within 1-2 months). Follow-up ranged from 6 to 1699.4 days after transplantation (mean 517.5 days, SD +/- 413.4; median 424 days). Of the recipients, 95% remained rejection-free during follow-up, with an actuarial rejection-free probability of 96.61% within 3 months. Three patients had episodes of biopsy-proven acute cellular rejection (ACR). Actuarial patient and graft survival rates at 3 years were 82.09% and 75.61%. Six patients (10%) experienced sepsis. There was no evidence of cytomegalovirus infections or side-effects related to the basiliximab. We found zero de novo malignancy, although we observed 5 patients with metastatic spread of their primary malignancy during the follow-up. Basiliximab in association with tacrolimus and steroids is effective in reducing episodes of ACR and increasing ACR-free survival after ALRLT.
Collapse
Affiliation(s)
- S Gruttadauria
- Correspondence: Salvatore Gruttadauria, ISMETT (Istituto Mediterraneo Trapianti e Terapie ad Alta Specializzazione), Via E. Tricomi N. 1, 90127 Palermo, Italy, Tel +39 0912 192111, Fax +39 0912 192400, Email
| | | | | | | | | | | | | | | | | | | |
Collapse
|
37
|
Lopez MA, Etherington G, Castellani CM, Franck D, Hurtgen C, Marsh JW, Nosske D, Doerfel H, Andrasi A, Bailey M, Balashazy I, Battisti P, Bérard P, Berkowski V, Birchall A, Blanchardon E, Bonchuk Y, de Carlan L, Cantone MC, Challeton-de Vathaire C, Cruz-Suarez R, Davis K, Dorrian D, Giussani A, Le Guen B, Hodgson A, Jourdain JR, Koukouliou V, Luciani A, Malatova I, Molokanov A, Moraleda M, Muikku M, Oeh U, Puncher M, Rahola T, Ratia H, Stradling N. Coordination of research on internal dosimetry in Europe: the CONRAD project. Radiat Prot Dosimetry 2007; 127:311-6. [PMID: 17686965 DOI: 10.1093/rpd/ncm350] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/16/2023]
Abstract
The EUropean RAdiation DOSimetry Group (EURADOS) initiated in 2005 the CONRAD Project, a Coordinated Network for Radiation Dosimetry funded by the European Commission (EC), within the 6th Framework Programme (FP). The main purpose of CONRAD is to generate a European Network in the field of Radiation Dosimetry and to promote both research activities and dissemination of knowledge. The objective of CONRAD Work Package 5 (WP5) is the coordination of research on assessment and evaluation of internal exposures. Nineteen institutes from 14 countries participate in this action. Some of the activities to be developed are continuations of former European projects supported by the EC in the 5th FP (OMINEX and IDEAS). Other tasks are linked with ICRP activities, and there are new actions never considered before. A collaboration is established with CONRAD Work Package 4, dealing with Computational Dosimetry, to organise an intercomparison on Monte Carlo modelling for in vivo measurements of (241)Am deposited in a knee phantom. Preliminary results associated with CONRAD WP5 tasks are presented here.
Collapse
Affiliation(s)
- M A Lopez
- CIEMAT, Avda Complutense 22, 28040 Madrid, Spain.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
38
|
Birchall A, Puncher M, Marsh JW, Davis K, Bailey MR, Jarvis NS, Peach AD, Dorrian MD, James AC. IMBA Professional Plus: a flexible approach to internal dosimetry. Radiat Prot Dosimetry 2007; 125:194-7. [PMID: 17132655 DOI: 10.1093/rpd/ncl171] [Citation(s) in RCA: 65] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/12/2023]
Abstract
IMBA (Integrated Modules for Bioassay Analysis) is a suite of software modules that implement the current ICRP biokinetic and dosimetric models for estimation of intakes and doses. The IMBA modules have gone through extensive quality assurance, and are now used for routine formal dose assessment by Approved Dosimetry Services throughout the UK. HPA has continued to develop the IMBA modules. In addition, several projects, sponsored by organisations both in the USA and in Canada, have resulted in the development of customised user-friendly interfaces (IMBA Expert 'editions'). These enable users not only to use the standard ICRP models, but also to change many of the parameter values from ICRP defaults, and to apply sophisticated data handling techniques to internal dose calculations. These include: fitting measurement data with the maximum likelihood method; using multiple chronic and acute intakes; and dealing with different data types, such as urine, faces and whole body simultaneously. These interfaces were improved further as a result of user-feedback, and a general 'off-the-shelf' product, IMBA Professional, was developed and made available in January 2004. A new version, IMBA Professional Plus, was released in April 2005, which is both faster and more powerful than previous software. The aim of this paper is to describe the capabilities of IMBA Professional Plus, and the mathematical methods used.
Collapse
Affiliation(s)
- A Birchall
- Radiation Protection Division, Health Protection Agency, Chilton, Didcot, Oxon. OX11 0RQ, UK.
| | | | | | | | | | | | | | | | | |
Collapse
|
39
|
Puncher M, Birchall A, Marsh JW. The autocorrelation coefficient as a tool for assessing goodness of fit between bioassay predictions and measurement data. Radiat Prot Dosimetry 2007; 127:370-3. [PMID: 17553862 DOI: 10.1093/rpd/ncm289] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/15/2023]
Abstract
Project IDEAS has produced guidelines for internal dose assessment. An integral part of this process is assessing the goodness of fit of biokinetic models to bioassay data. It is recommended that a fit should only be accepted if (a) it is close enough to the data not to be rejected by a chi2 test and (b) if it looks acceptable to 'the eye'. The latter criterion was added to enable the assessor to reject fits which seemed to display some sort of systematic bias. However, there are problems with both of these tests: (a) the chi2 test is dependent on the assumed uncertainties which are often unknown, (b) 'by eye' assessment is subjective. In this paper, another statistic, the autocorrelation coefficient of the residuals, rho, is investigated. The main advantages of the rho statistic are that it is objective, very sensitive to biasing and independent of the assumed errors.
Collapse
Affiliation(s)
- M Puncher
- Radiation Protection Division, HPA Centre for Radiation, Chemical and Environmental Hazards, Chilton, Didcot, Oxon OX11 0RQ, UK.
| | | | | |
Collapse
|
40
|
Gamblin TC, Geller DA, Marsh JW, Carr B. Gemcitabine-based transcatheter arterial chemoembolization for unresectable cholangiocarcinoma in thirty-eight patients: Single institutional experience. J Clin Oncol 2006. [DOI: 10.1200/jco.2006.24.18_suppl.14152] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
14152 Background: Survival for patients with unresectable cholangiocarcinoma is reported to be 5–8 months. Systemic chemotherapy has been disappointing and not shown to significantly improve survival. Transcatheter arterial chemoembolization (TACE) has been shown to prolong survival in hepatocellular carcinoma patients but experience with cholangiocarcinoma is limited. We report our experience with the well-tolerated drug gemcitabine. Methods: Thirty-eight patients with unresectable cholangiocarcinoma were treated with one or more cycles of gemcitabine-based TACE between 2001 and 2005 at our institution. Follow-up imaging was performed on all patients after each TACE procedure. Regimens of TACE included: gemcitabine only (16), gemcitabine followed by cisplatin (2), gemcitabine followed by oxaliplatin (5), gemcitabine and cisplatin (12), and gemcitabine and cisplatin followed by oxaliplatin (3). Actual survival is reported, as 35 of 38 have died from disease (92%). Results: Patients were 57.5 years of age (range 36–87) and a median of 3 treatments (range 1–10) were administered. Median survival from time of first treatment was 10.3 months. Patients receiving gemcitabine followed by cisplatin or oxaliplatin had improved survival (mean 16.5 and 10.5 months respectively) when compared to gemcitabine alone (mean 6 months). Patients receiving gemcitabine and cisplatin as a combination had improved survival (mean 13.4 months) compared to single agent gemcitabine. Patients who progressed on gemcitabine and cisplatin and then received oxaliplatin also showed improved survival (mean 14.3 months) compared to gemcitabine only. Neutropenia, thrombocytopenia and hyperbilirubinemia were the most common toxicities observed. Three patients in the entire series exhibited grade 3 thrombocytopenia while seven patients had grade 3 and one had grade 4 bilirubin levels. Conclusions: This series provides evidence in favor of TACE rather than historically reported alternatives such as systemic chemotherapy or chemotherapy/RT. Our results suggest that gemcitabine based TACE is well tolerated and perhaps best delivered as a combination therapy for patients with unresectable cholangiocarcinoma. No significant financial relationships to disclose.
Collapse
Affiliation(s)
| | | | | | - B. Carr
- University of Pittsburgh, Pittsburgh, PA
| |
Collapse
|
41
|
Gruttadauria S, Cintorino D, Piazza T, Mandala L, Doffria E, Musumeci A, Di Trapani G, Arcadipane A, Scianna G, Spada M, Verzaro R, Volpes R, Vizzini G, Palazzo U, Minervini M, Marsh JW, Marcos A, Gridelli B. A Safe Immunosuppressive Protocol in Adult-to-Adult Living Related Liver Transplantation. Transplant Proc 2006; 38:1106-8. [PMID: 16757278 DOI: 10.1016/j.transproceed.2006.02.141] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
BACKGROUND In this series of 32 adult-to-adult living related liver transplantations, we assessed the efficacy and safety of basiliximab in combination with a tacrolimus-based regimen. Basiliximab, a chimeric monoclonal antibody directed against the alpha chain of the interleukin-2 (IL-2) receptor (CD25), has been extensively evaluated as induction therapy for cadaveric liver transplant recipients. PATIENTS AND METHODS Thirty-two adult-to-adult living related liver transplantations were performed in the last 3 years. All patients received two 20 mg doses of basiliximab (days 0 and 4 posttransplantation) followed by tacrolimus (0.15 mg/kg/d; 10-15 ng/mL target trough levels) and steroids (starting with 20 mg IV switched to PO as soon as the patient was able to eat and weaned within 1-2 months). The average follow-up was 395 days after transplantation. RESULTS Of the patients, 93.75% remained rejection-free during follow-up with an actuarial rejection-free probability of 92.59% within 3 months. Two patients (6%) had one episode of biopsy-proven acute cellular rejection (ACR). Actuarial patient and graft survival rates at 3 years were 86.85% and 81.25%. One patient (3%) experienced one episode of sepsis. There was no evidence of cytomegalovirus infections or side effects related to the basiliximab. We found zero de novo malignancy but we observed two patients with metastatic spread of their primary malignancy during the follow-up. CONCLUSION Basiliximab in association with tacrolimus and steroids is effective as prophylaxis of ACR among adult living related liver transplant recipients.
Collapse
Affiliation(s)
- S Gruttadauria
- Istituto Mediterraneo Trapianti e Terapie ad Atta Specializzazione (IsMeTT), Italy, Palermo.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
42
|
Puncher M, Marsh JW, Birchall A. Obtaining an unbiased estimate of intake in routine monitoring when the time of intake is unknown. Radiat Prot Dosimetry 2006; 118:280-9. [PMID: 16410294 DOI: 10.1093/rpd/nci345] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/06/2023]
Abstract
A common problem in internal dosimetry occurs in routine monitoring, when it is required to estimate an intake from a measurement made at the end of a monitoring interval, and the time of intake is unknown. ICRP suggests that, in these cases, it should be assumed that the intake occurred in the middle of the monitoring period. However, it has been shown that this will, in the long term, lead to biased estimates of a worker's intake and dose. In order to overcome this biasing, the United States Department of Energy (USDOE) recommends a different method based on calculating the intakes for all possible intake-times in the interval, and then taking an arithmetic average. In this paper, it is shown that both the ICRP and USDOE methods are biased. An alternative method is suggested, which assumes a constant chronic intake throughout the monitoring interval. Monte Carlo simulations are used to estimate the magnitude of bias for two realistic monitoring programmes using all three methods. It is shown that the proposed method is unbiased and also yields estimates of intake that are generally closer to the actual intake, than the other two. The Monte Carlo conclusions are backed up by a theoretical analysis of bias. Finally, the source of bias in the apparently intuitive approach of the USDOE method is revealed by viewing the problem from a Bayesian perspective.
Collapse
Affiliation(s)
- M Puncher
- Health Protection Agency, Centre for Radiation, Chemical and Environmental Hazards, Radiation Protection Division, Chilton, Didcot, Oxon OX11 0RQ, UK.
| | | | | |
Collapse
|
43
|
Abstract
In 1997, a collaboration between British Nuclear Fuels plc (BNFL), Westlakes Research Institute and NRPB started, with the aim of producing IMBA (Integrated Modules for Bioassay Analysis), a suite of software modules that implement the new ICRP models for estimation of intakes and doses. This was partly in response to new UK regulations, and partly due to the requirement for a unified approach in estimating intakes and doses from bioassay measurements within the UK. Over the past 5 years, the IMBA modules have been developed further, have gone through extensive quality assurance, and are now used for routine dose assessment by approved dosimetry services throughout the UK. More recently, interest in the IMBA methodology has been shown by the United States Department of Energy (USDOE), and in 2001 an ambitious project to develop a software package (IMBA Expert USDOE Edition) which would meet the requirements of all of the major USDOE sites began. Interest in IMBA Expert is now being expressed in many other countries. The aim of this paper is to outline the origin and evolution of the IMBA modules (the past); to describe the full capabilities of the current IMBA Expert system (the present) and to indicate possible future directions in terms of capabilities and availability (the future).
Collapse
Affiliation(s)
- A Birchall
- National Radiological Protection Board, Chilton, Didcot, Oxon OX11 0RQ, UK.
| | | | | | | | | | | | | | | |
Collapse
|
44
|
Speed J, Birchall A, Bull R, Cockerill R, Jarvis NS, Marsh JW, Peace MS, Roberts G, Scarlett C, Spencer D, Stewart P. UK laboratory intercomparison on internal dosimetry. Radiat Prot Dosimetry 2003; 104:221-229. [PMID: 14565728 DOI: 10.1093/oxfordjournals.rpd.a006185] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/24/2023]
Abstract
A laboratory intercomparison for internal dose assessment from a variety of intake scenarios is described. This is the first UK intercomparison using the revised ICRP Human Respiratory Tract and biokinetic models. Four United Kingdom laboratories participated and six cases were assessed. Overall, the agreement in internal dose assessments between laboratories was considered satisfactory with 79% of the assessed committed effective doses, e(50), for cases within a band of +/- 40% of the median value. The range (highest/lowest) in e(50) estimated by the laboratories was smallest (1.2) for a case involving inhalation of 137Cs. The range was greatest (6.0) for a case involving a wound with, and possible inhalation of, 238Pu, 239Pu and 241Am; the variation between laboratories in assessment of intakes could not be considered to be satisfactory in this case. Judgements on the most appropriate data to use in estimating intakes, choice of parameter values for use with the ICRP models and allowing for the effects of treatment with DTPA were important sources of variability between laboratories.
Collapse
|
45
|
Birchall A, Marsh JW. Response to comments on 'Uncertainty analysis of the weighted equivalent lung dose per unit exposure to radon progeny in the home' by J. W. Marsh et al. Radiat Prot Dosimetry 2003; 104:177-178. [PMID: 12918796 DOI: 10.1093/oxfordjournals.rpd.a006179] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/24/2023]
|
46
|
|
47
|
Butterweck G, Schuler C, Vezzù G, Müller R, Marsh JW, Thrift S, Birchall A. Experimental determination of the absorption rate of unattached radon progeny from respiratory tract to blood. Radiat Prot Dosimetry 2002; 102:343-348. [PMID: 12474944 DOI: 10.1093/oxfordjournals.rpd.a006103] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/24/2023]
Abstract
An exposure methodology was developed for the determination of the absorption rate of unattached radon progeny deposited in the human respiratory tract to blood. Twenty-one volunteers were exposed in a radon chamber during well-controlled aerosol and radon progeny conditions, with predominantly unattached radon daughters. Special efforts were made to restrict the dose to the volunteers to an absolute maximum of 0.08 mSv. Measurements of radon gas and radon progeny in blood samples of these volunteers indicated absorption half times of 20 min to 60 min. Former determinations, mainly performed with much larger aerosol particles of diameters between 100 nm and 1,000 nm, implied absorption half times around 10 h. This indicates that the absorption of radon decay products from ciliated airways into blood is dependent upon particle size and particle composition.
Collapse
Affiliation(s)
- G Butterweck
- Paul Scherrer Institut, CH-5232 Villigen PSI, Switzerland.
| | | | | | | | | | | | | |
Collapse
|
48
|
Marsh JW, Birchall A, Butterweck G, Dorrian MD, Huet C, Ortega X, Reineking A, Tymen G, Schuler C, Vargas A, Vezzu G, Wendt J. Uncertainty analysis of the weighted equivalent lung dose per unit exposure to radon progeny in the home. Radiat Prot Dosimetry 2002; 102:229-248. [PMID: 12430962 DOI: 10.1093/oxfordjournals.rpd.a006092] [Citation(s) in RCA: 20] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/24/2023]
Abstract
A parameter uncertainty analysis has been performed to derive the probability distribution of the weighted equivalent dose to lung for an adult (w(lung) H(lung)) per unit exposure to radon progeny in the home. The analysis was performed using the ICRP Publication 66 human respiratory tract model (HRTM) with tissue weighting factor for the lung, w(lung) = 0.12 and the radiation weighting factor for alpha particles, wR = 20. It is assumed that the HRTM is a realistic representation of the physical and biological processes, and that the parameter values are uncertain. The parameter probability distributions used in the analysis were based on a combination of experimental results and expert judgement from several prominent European scientists. The assignment of the probability distributions describing the uncertainty in the values of the assigned fractions (ABB, Abb, AAI) of the tissue weighting factor proved difficult in practice due to lack of quantitative data. Because of this several distributions were considered. The results of the analysis give a mean value of w(lung) H(lung) per unit exposure to radon progeny in the home of 15 mSv per working level month (WLM) for a population. For a given radon gas concentration, the mean value of w(lung) H(lung) per unit exposure is 13 mSv per 200 Bq.m(-3).y of 222Rn. Parameters characterising the distributions of w(lung) H(lung) per unit exposure are given. If the ICRP weighting factors are fixed at their default values (ABB, Abb, AAI = 0.333, 0.333, 0.333; w(lung) = 0.12; and wr = 20) then on the basis of this uncertainty analysis it is extremely unlikely (P approximately 0.0007) that a value of Hw/Pp for exposure in the home is as low as 4 mSv per WLM, the value determined with the epidemiological approach. Even when the uncertainties in the ABB, Abb, AAI, values are included then this probability is predicted to be between 0.01 to 0.08 depending upon the distribution assumed for describing the uncertainties in the ABB, Abb, AAI, values. Thus, it is concluded that the uncertainties in the HRTM parameters considered in this study cannot totally account for the discrepancy between the dosimetric and epidemiological approaches.
Collapse
Affiliation(s)
- J W Marsh
- National Radiological Protection Board, Didcot, Oxon, UK.
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
49
|
Abstract
Piggyback orthotopic liver transplantation (LTx) has permitted the elimination of extra-corporeal venovenous bypass. In some instances, an internal temporary portocaval shunt has to be constructed in order to prevent hemodynamic instability. We describe a technique in which a donor iliac vein graft is used to bridge the distance between the portal vein and vena cava in cases where a direct shunt cannot be constructed. This technique can be applied to liver Tx as well as to liver and small bowel Tx.
Collapse
Affiliation(s)
- E P Molmenti
- The Johns Hopkins Hospital, 600 N. Wolfe Street, Baltimore, MD 21287, USA.
| | | | | | | | | |
Collapse
|
50
|
Kirimlioglu H, Dvorchick I, Ruppert K, Finkelstein S, Marsh JW, Iwatsuki S, Bonham A, Carr B, Nalesnik M, Michalopoulos G, Starzl T, Fung J, Demetris A. Hepatocellular carcinomas in native livers from patients treated with orthotopic liver transplantation: biologic and therapeutic implications. Hepatology 2001; 34:502-10. [PMID: 11526535 PMCID: PMC2956439 DOI: 10.1053/jhep.2001.26633] [Citation(s) in RCA: 55] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/06/2023]
Abstract
The gross and histopathologic characteristics of 212 nonfibrolamellar hepatocellular carcinomas (HCCs) discovered in native livers removed at the time of liver transplantation were correlated with features of invasive growth and tumor-free survival. The results show that most HCCs begin as small well-differentiated tumors that have an increased proliferation rate and induce neovascularization, compared with the surrounding liver. But at this stage, they maintain a near-normal apoptosis/mitosis ratio and uncommonly show vascular invasion. As tumors enlarge, foci of dedifferentiation appear within the neoplastic nodules, which have a higher proliferation rate and show more pleomorphism than surrounding better-differentiated areas. Vascular invasion, which is the strongest predictor of disease recurrence, correlates significantly with tumor number and size, tumor giant cells and necrosis, the predominant and worst degree of differentiation, and the apoptosis/mitosis ratio. In the absence of macroscopic or large vessel invasion, largest tumor size (P <.006), apoptosis/mitosis ratio (P <.03), and number of tumors (P <.04) were independent predictors of tumor-free survival and none of 24 patients with tumors having an apoptosis/mitosis ratio greater than 7.2 had recurrence. A minority of HCCs (<15%) quickly develop aggressive features (moderate or poor differentiation, low apoptosis/mitosis ratio, and vascular invasion) while still small, similar to flat carcinomas of the bladder and colon. In conclusion, hepatic carcinogenesis in humans is a multistep and multifocal process. As in experimental animal studies, aggressive biologic behavior (vascular invasion and recurrence) correlates significantly with profound alterations in the apoptosis/mitosis ratio and with architectural and cytologic alterations that suggest a progressive accumulation of multiple genetic abnormalities.
Collapse
Affiliation(s)
- H Kirimlioglu
- Thomas E. Starzl Transplantation Institute, University of Pittsburgh Medical Center, Pittsburgh, PA 15261, USA
| | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|